Mc. Audet et al., Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive - A randomized controlled trial, J AM MED A, 285(18), 2001, pp. 2347-2354
Citations number
23
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Context Oral contraceptive (OC) pills are effective, but poor compliance in
creases rates of pregnancy during treatment.
Objective To compare the contraceptive efficacy, cycle control, compliance,
and safety of a transdermal contraceptive patch and an OC,
Design Randomized, open-label, parallel-group trial conducted October 1997
to June 1999.
Setting Forty-five clinics in the United States and Canada.
Participants A total of 1417 healthy adult women of child-bearing potential
.
Interventions Participants were randomly assigned to receive a transdermal
contraceptive patch (n=812) vs an OC (n=605) for 6 or 13 cycles. Patch trea
tment consisted of application of 3 consecutive 7-day patches followed by 1
patch-free week.
Main Outcome Measures Overall and method-failure Pearl Indexes (number of p
regnancies/100 person-years of use) and life-table estimates of the probabi
lity of pregnancy were calculated. Cycle control, compliance, patch adhesio
n, and adverse events were also assessed.
Results Overall and method-failure Pearl Indexes were numerically lower wit
h the patch (1.24 and 0.99, respectively) vs the OC (2.18 and 1.25, respect
ively); this difference was not statistically significant (P=.57 and .80, r
espectively), The incidence of breakthrough bleeding and/or spotting was si
gnificantly higher only in the first 2 cycles in the patch group, but the i
ncidence of breakthrough bleeding alone was comparable between treatments i
n all cycles. The mean proportion of participants' cycles with perfect comp
liance was 88.2% (811 total participants, 5141 total cycles) with the patch
and 77.7% (605 total participants, 4134 total cycles) with the OC (P <.001
). Only 1.8% (300/16673) of patches completely detached. Both treatments we
re similarly well tolerated; however, application site reactions, breast di
scomfort, and dysmenorrhea were significantly more common in the patch grou
p.
Conclusion The contraceptive patch is comparable to a combination OC in con
traceptive efficacy and cycle control. Compliance was better with the weekl
y contraceptive patch than with the OC.